MA53141A - Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate - Google Patents
Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostateInfo
- Publication number
- MA53141A MA53141A MA053141A MA53141A MA53141A MA 53141 A MA53141 A MA 53141A MA 053141 A MA053141 A MA 053141A MA 53141 A MA53141 A MA 53141A MA 53141 A MA53141 A MA 53141A
- Authority
- MA
- Morocco
- Prior art keywords
- differentiating
- processes
- prostate cancer
- prostatic hyperplasia
- hyperplasia under
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/342—Prostate diseases, e.g. BPH, prostatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697292P | 2018-07-12 | 2018-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53141A true MA53141A (fr) | 2021-05-19 |
Family
ID=69138842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053141A MA53141A (fr) | 2018-07-12 | 2019-07-12 | Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200018758A1 (fr) |
| EP (1) | EP3821031A4 (fr) |
| AU (1) | AU2019301756B2 (fr) |
| CA (1) | CA3106191A1 (fr) |
| MA (1) | MA53141A (fr) |
| WO (1) | WO2020014593A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000029948A1 (it) * | 2020-12-04 | 2022-06-04 | Nib Biotec S R L | Metodo per la diagnosi di tumore alla prostata in pazienti in differente fascia di età |
| GB202111635D0 (en) * | 2021-08-13 | 2021-09-29 | Randox Laboratories | Risk prediction model for prostate cancer |
| CN118497334B (zh) * | 2024-06-05 | 2025-08-01 | 武汉大学中南医院 | 抑制flnc基因表达的物质在制备治疗良性前列腺增生的药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6482599B1 (en) * | 1999-04-30 | 2002-11-19 | Hybritech Incorporated | Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such |
| UA62739A (en) * | 2003-05-14 | 2003-12-15 | Nat Tech Univ Kyiv Polytech | A method for applying silicide coatings on the steels surface |
| WO2013173517A1 (fr) * | 2012-05-15 | 2013-11-21 | Mcclelland, Michael | Marqueurs biologiques du stroma pour le diagnostic du cancer de la prostate |
| US10539566B2 (en) * | 2014-12-08 | 2020-01-21 | Berg Llc | Use of markers including filamin A in the diagnosis and treatment of prostate cancer |
| WO2018085441A1 (fr) * | 2016-11-01 | 2018-05-11 | Berg Llc | Protéines de liaison de filamine b et leurs utilisations |
| US10759850B2 (en) * | 2016-11-01 | 2020-09-01 | Berg Llc | Filamin A binding proteins and uses thereof |
-
2019
- 2019-07-12 MA MA053141A patent/MA53141A/fr unknown
- 2019-07-12 CA CA3106191A patent/CA3106191A1/fr active Pending
- 2019-07-12 US US16/509,808 patent/US20200018758A1/en not_active Abandoned
- 2019-07-12 EP EP19833401.3A patent/EP3821031A4/fr active Pending
- 2019-07-12 WO PCT/US2019/041570 patent/WO2020014593A1/fr not_active Ceased
- 2019-07-12 AU AU2019301756A patent/AU2019301756B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019301756A1 (en) | 2021-01-28 |
| WO2020014593A8 (fr) | 2020-03-12 |
| CA3106191A1 (fr) | 2020-01-16 |
| EP3821031A4 (fr) | 2022-07-20 |
| AU2019301756B2 (en) | 2026-02-05 |
| EP3821031A1 (fr) | 2021-05-19 |
| US20200018758A1 (en) | 2020-01-16 |
| WO2020014593A1 (fr) | 2020-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3433238A4 (fr) | Agents à affinité élevée ayant pour cible un antigène membranaire spécifique de la prostate, utilisés pour l'endoradiothérapie du cancer de la prostate | |
| EP3589732A4 (fr) | Détection du cancer de la prostate | |
| ZA202006008B (en) | Psma-targeted radiopharmaceutical for diagnosing and treating prostate cancer | |
| DK3336197T3 (da) | Epigenetiske markører og relaterede fremgangsmåder og midler til detektion og behandling af ovariekræft | |
| MX2022008100A (es) | Uso de compuestos de cloroquina y clemizol para el tratamiento de afecciones inflamatorias y cancerosas. | |
| IL276748A (en) | Methods for the detection and treatment of prostate cancer | |
| LT3490560T (lt) | Būdas prostatos vėžiui gydyti naudojant niraparibą | |
| EP3433383A4 (fr) | Procédés d'amplification quantitative | |
| MA53141A (fr) | Procédés de différenciation de l'hyperplasie prostatique bénigne d'un cancer de la prostate | |
| EP3565560A4 (fr) | Procédés prédictifs et diagnostiques pour le cancer de la prostate | |
| EP3775171A4 (fr) | Procédés de traitement d'un cancer résiduel minimal | |
| EP3894561A4 (fr) | Procédés de traitement du cancer | |
| IL288408A (en) | Methods of treating urinary system cancers | |
| EP3691536A4 (fr) | Appareil et procédé de détermination de probabilité spatiale d'un cancer dans la prostate | |
| IL285056A (en) | Prostate cancer treatment methods based on molecular subtypes | |
| IL281281A (en) | Combination therapy for the treatment of prostate cancer | |
| EP4087585A4 (fr) | Compositions et procédés de prévention de la récurrence de cancer | |
| EP3426310A4 (fr) | Biopsie de liquide prostatique pour la détection du cancer de la prostate et de l'hyperplasie bénigne de la prostate | |
| EP3830134A4 (fr) | Compositions et procédés de détection du cancer de la prostate | |
| EP3425392A4 (fr) | Procédé de détection d'un cancer de la prostate résistant à la castration et réactif de détection | |
| EP3864415A4 (fr) | Procédés de prise de décisions de traitement du cancer de la prostate | |
| EP3816628A4 (fr) | Marqueur de détermination du cancer du pancréas | |
| EP3405583A4 (fr) | Compositions et procédés pour le dépistage et l'identification d'un cancer de la prostate cliniquement agressif | |
| EP3470528A4 (fr) | Méthode de prédiction de l'effet d'une pharmacothérapie sur le cancer | |
| EP3415637A4 (fr) | Procédé d'identification de développement de carcinome basaloïde cellulaire de l' sophage |